DRUG NAME CLASSIFICATIO MECHANIS INDICATION CONTRAINDICATIO ADVERSE NURSING

N M OF S NS REACTIONS RESPONSIBILITI
ACTION ES
Generic name: sulfonylureas It belongs to is indicated as low blood sugar.  Blisterin Before:
Chlorpropamide the an adjunct to pituitary hormone g, assess for signs and
sulfonylurea diet and deficiency. peeling, symptoms of
class of exercise to or hypoglycemia,
a condition where the
Brand name: insulin improve loosenin
adrenal glands produce
diabinese secretagogues glycemic g of the
less hormones called
, which act control in skin
Addison's disease.
by stimulatin adults with type  cracks in
g cells of the 2 diabetes glucose-6-phosphate
dehydrogenase (G6PD) the skin
Actual pancreas to mellitus. There
dosage/route/frequen release is no fixed deficiency.  loss of
cy insulin. dosage regimen hepatic porphyria. heat
tablet Sulfonylureas for the from the After:
a type of blood disorder
 100mg increase both management of body Monitor patient
where the red blood
 250mg basal insulin type 2 diabetes cells burst called  red, response to therapy
Middle-aged stable secretion and with hemolytic anemia. irritated (stabilization of
diabetic meal- DIABINESE eyes blood glucose
 250 mg/day stimulated (chlorpropamid levels). Monitor for
 red,
PO initially; insulin e) or any other swollen adverse effects
may increase release. hypoglycemic skin (hypoglycemia and
or decrease agent. gastrointestinal
PRN by 50-  scaly distress). Evaluate
125 mg/day at skin patient
3- to 5-day understanding on
intervals drug therapy by
Older patients asking patient to
 100-125 name the drug, its
mg/day PO indication, and
initially; may adverse effects to
increase or watch for.
decrease PRN
by 50-125
mg/day at 3- to
 5-day intervals
Maintenance dose
 100-250
mg/day; a
higher dose of
500 mg/day
may be
required in
severe
diabetes;
should avoid
doses >750
mg/day

Time given to the

patient:
Administer 30
minutes before meal
to improve
absorption